# Cogent Biosciences, Inc. (COGT) - Q4 2025 earnings

Reported February 17, 2026.

| | Reported | Consensus estimate |
| --- | --- | --- |
| Revenue | Not available | $1.7M |
| EPS | $-0.55 | $-0.51 |

Earnings filing reader: [8-K 0001193125-26-053131](https://www.opencapital.sh/filings/0001193125-26-053131)
Agent-readable filing: [Markdown](https://www.opencapital.sh/filings/0001193125-26-053131.md)
Original filing: [SEC.gov filing index](https://www.sec.gov/Archives/edgar/data/1622229/000119312526053131/0001193125-26-053131-index.htm)
Periodic report: 10-K - https://www.sec.gov/Archives/edgar/data/1622229/000119312526053334/0001193125-26-053334-index.htm
Canonical page (please cite this URL): https://www.opencapital.sh/stocks/cogt/earnings/q4-2025